RecruitingNCT03667417

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Sponsor

Institut Paoli-Calmettes

Enrollment

5,000 participants

Start Date

Oct 15, 1999

Study Type

OBSERVATIONAL

Conditions

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Min Age: 18 Years

Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation, aged 18 years and over.
Woman with or without breast cancer or ovarian cancer at baseline.
Man with or without breast cancer at baseline.
Signed consent to participation
Affiliation to a social security regimen, or beneficiary of such a regimen.

A person of legal age subject to a legal protection measure, or unable to express consent.
Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons

OTHERQuestionnaires

standardized data collection and 10-year prospective follow-up

Institut Paoli-Calmettes

Marseille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT03667417